Marie Fugitt
Nurse Practitioner · Fairfax, VANPI 1073891529
Payments from drug & device makers
Across 198 payments — averaging $23.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$733
- Pfizer$638
- AbbVie$601
- Lilly USA, LLC$261
- AstraZeneca$234
- Astellas Pharma US Inc$171
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,687100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 37 | $733 |
| Pfizer | 27 | $638 |
| AbbVie | 34 | $601 |
| Lilly USA, LLC | 15 | $261 |
| AstraZeneca | 8 | $234 |
| Astellas Pharma US Inc | 8 | $171 |
| Amgen(2 entities) | 7 | $154 |
| GSK | 7 | $146 |
| Inspire Medical Systems, Inc. | 1 | $127 |
| Johnson & Johnson | 1 | $127 |
| Exact Sciences | 5 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $117 |
| Abbott | 5 | $115 |
| Sanofi | 1 | $111 |
| Aimmune Therapeutics, Inc. | 1 | $110 |
| Phathom Pharmaceuticals, Inc. | 2 | $108 |
| Axsome Therapeutics, Inc. | 1 | $105 |
| Currax Pharmaceuticals LLC | 6 | $98 |
| Gilead | 2 | $96 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $86 |
| Sage Therapeutics, LLC | 1 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Clarus Therapeutics Inc. | 2 | $32 |
| Merck | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Novartis | 1 | $26 |
| Boehringer Ingelheim | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $22 |
| Kaleo, Inc. | 1 | $20 |
| Optinose US, Inc. | 1 | $20 |
| Watermark Medical, Inc. | 1 | $18 |
| Avion Pharmaceuticals | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,687 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $21,281 |
| EliquisApixaban | 15 | $15,701 |
| MounjaroTirzepatide | 15 | $14,248 |
| SynthroidLevothyroxine Sodium | 29 | $2,408 |
| PaxlovidNirmatrelvir/Ritonavir | 13 | $1,429 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,300 |
| Rosuvastatin Calcium | 95 | $1,097 |
| Metoprolol Succinate | 40 | $1,064 |
| Levothyroxine Sodium | 96 | $997 |
| Montelukast Sodium | 37 | $887 |
| Atorvastatin Calcium | 99 | $858 |
| Potassium Chloride | 24 | $857 |
| Losartan Potassium | 73 | $706 |
| Gabapentin | 26 | $646 |
| Trazodone Hcl | 45 | $551 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $733 | $21,28118 claims |
| PfizerEliquis, Paxlovid | $638 | $17,13128 claims |
| Lilly USA, LLCMounjaro | $261 | $14,24815 claims |
| AbbVieSynthroid | $601 | $2,40829 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Other nurse practitioner in Fairfax
- Pamela StenborgFairfax$8K
- Wendy HoltFairfax$7K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Ashley CarmenAlexandria$99K
- Rachel AndersonCharlottesville$90K
- Megan FrancisArlington$81K
- Elizabeth WilletteNorfolk$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.